Daiichi Sankyo begins patient dosing in QuANTUM-Wild phase 3 trial of Vanflyta in newly diagnosed FLT3-ITD negative AML: Tokyo Thursday, December 12, 2024, 12:00 Hrs [IST] The fir ...

Daiichi Sankyo has announced the dosage of the first subject in the randomised Phase III QuANTUM-Wild trial of oral Vanflyta ...

The first patient has been dosed in the QuANTUM-Wild phase 3 trial evaluating Daiichi Sankyo’s (TSE: 4568) VANFLYTA® ...

The suspected madman behind a deadly stabbing spree in Manhattan Monday has a long criminal history — and had just walked free from Rikers Island a month before the terrifying attacks, The Post ...

Blood cancer sufferers across the country are celebrating after two new drugs were approved on the NHS in Scotland. Regulators in Scotland, the Scottish Medicines Consortium (SMC), gave the green ...

Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages. Daiichi Sankyo’s drug, quizartinib (Vanflyta) has also been recommended by the SMC for acute ...

Representative Kevin Kiley (R-Roseville) announced Wednesday that he plans to introduce a bill to eliminate federal funding for the California High-Speed Rail project. “California’s … ...

© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.

Last year, Nkarta was celebrating data which showed that its natural killer (NK) cell therapy for acute myeloid leukaemia (AML) was showing remarkable efficacy in hard-to-treat patients, but its ...